The investment will support the launch of NATLEAN in January 2027 and expand Metabolize's portfolio of proprietary products powered by Precision Metabolite™ Technology. SAN FRANCISCO, Oct. 15, 2026 /PRNewswire/ -- Metabolize, a science-first consumer health company built on Stanford...